Skip to main content
SpringerLink
Log in

Farmaci interferenti sull’azione recettoriale dei glicocorticoidi

  • Commissione Farmaci della S.I.E.
  • Interferenze farmacologiche sulla diagnostica ormonale dell’asse ipotalamo-ipofisi-surrene (HPA)
  • Published:
L’Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Jung-Testas I, Baulieu EE. Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor. Exp Cell Res 147: 177, 1983.

    Article  CAS  PubMed  Google Scholar 

  2. Bertagna X, Bertagna C, Luton JP, Husson JM, Girard F. The new steroid analog RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab 59: 25, 1984.

    Article  CAS  PubMed  Google Scholar 

  3. Gaillard RC, Riondel A, Muller AF, Herrmann W, Baulieu EE. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci USA 81: 3879, 1984.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Laue L, Lotze MT, Chrousos GP, Barnes K, Loriaux DL, Fleisher TA. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects. J Clin Endocrinol Metab 71: 1474, 1990

    Article  CAS  PubMed  Google Scholar 

  5. Heikinheimo O, Raivio T, Honkanen H, Ranta S, Jänne OA., Termination of pregnancy with mifepristone and prostaglandin suppresses transiently circulating glucocorticoid bioactivity. J Clin Endocrinol Metab 88: 323, 2003.

    Article  CAS  PubMed  Google Scholar 

  6. Philibert D, Teutsch G. RU 486 development. Science 247: 622, 1990.

    Article  CAS  PubMed  Google Scholar 

  7. Teutsch G, Gaillard-Moguilewsky M, Lemoine G, Nique F, Philibert D. Design of ligands for the glucocorticoid and progestin receptors. Biochem Soc Trans 19: 901, 1991.

    CAS  PubMed  Google Scholar 

  8. Poulin R, Baker D, Poirier D, Labrie F. Multiple actions of synthetic ‘progestins’ on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids. Breast Res Treat 17: 197, 1991.

    Article  CAS  Google Scholar 

  9. Honer C, Nam K, Fink C, Marshall P, Ksander G, Chatelain RE, Cornell W, Steele R, Schweitzer R, Schumacher C. Glucocorticoid receptor antagonism by cyproterone acetate and RU486. Mol Pharmacol 63: 1012, 2003.

    Article  CAS  PubMed  Google Scholar 

  10. Poyet P, Labrie F. Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate. Mol Cell Endocrinol 42: 283, 1985

    Article  CAS  PubMed  Google Scholar 

  11. Lamberts SW, Uitterlinden P, de Jong FH. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue. Cancer Res 48: 6063, 1988.

    CAS  PubMed  Google Scholar 

  12. Hellman L, Yoshida K, Zumoff B, Levin J, Kream J, Fukushima DK. The effect of medroxyprogesterone acetate on the pituitary-adrenal axis. J Clin Endocrinol Metab 42: 912, 1976.

    Article  CAS  PubMed  Google Scholar 

  13. Kontula K, Paavonen T, Luukkainen T, Andersson LC. Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol 32: 1511, 1983.

    Article  CAS  PubMed  Google Scholar 

  14. Ishida Y, Ishida Y, Heersche JN. Pharmacologic doses of medroxyprogesterone may cause bone loss through glucocorticoid activity: an hypothesis. Osteoporosis Int 13: 601, 2002.

    Article  CAS  Google Scholar 

  15. Steer KA, Kurtz AB, Honour JW. Megestrol-induced Cushing’s syndrome. Clin Endocrinol 42: 91, 1995.

    Article  CAS  Google Scholar 

  16. Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M. Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Arch Intern Med 157: 1651, 1997.

    Article  CAS  PubMed  Google Scholar 

  17. Fuhrmann U, Slater EP, Fritzmeier KH. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays. Contraception 51: 45, 1995.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unità di Endocrinologia, Dipartimento di Fisiopatologia Clinica, Università di Firenze, V.le Pieraccini 6, 50139, Firenze, Italia

    Alessandro Peri

Authors
  1. Alessandro Peri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Peri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peri, A. Farmaci interferenti sull’azione recettoriale dei glicocorticoidi. L’Endocrinologo 9, 91–94 (2008). https://doi.org/10.1007/BF03344616

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03344616

Search

Navigation